Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 30, 2024 |
referred to health delivered to assembly passed senate |
Jan 16, 2024 |
advanced to third reading |
Jan 09, 2024 |
2nd report cal. |
Jan 08, 2024 |
1st report cal.80 |
Jan 03, 2024 |
referred to health |
Dec 20, 2023 |
print number 4786a |
Dec 20, 2023 |
amend and recommit to health |
Feb 14, 2023 |
referred to health |
Senate Bill S4786A
2023-2024 Legislative Session
Sponsored By
(D, WF) 33rd Senate District
Current Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
Bill Amendments
2023-S4786 - Details
2023-S4786 - Summary
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
2023-S4786 - Sponsor Memo
BILL NUMBER: S4786 SPONSOR: RIVERA TITLE OF BILL: An act to amend the public health law, in relation to enacting the "New York affordable drug manufacturing act" PURPOSE: Enacts the "New York affordable drug manufacturing act". SUMMARY OF SPECIFIC PROVISIONS: Section 1 provides a short title, the "New York affordable drug manufac- turing act." Section 2 amends article 2-A of the public health law by adding a new title IV, the New York Affordable Drug Manufacturing Act, which will help increase patient access to affordable drugs. This section provides definitions for the terms "generic drug" and "partnerships." This
2023-S4786 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 4786 2023-2024 Regular Sessions I N S E N A T E February 14, 2023 ___________ Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to enacting the "New York affordable drug manufacturing act" THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Short title. This act shall be known and may be cited as the "New York affordable drug manufacturing act". § 2. Article 2-A of the public health law is amended by adding a new title IV to read as follows: TITLE IV NEW YORK AFFORDABLE DRUG MANUFACTURING ACT SECTION 282. DEFINITIONS. 283. PARTNERSHIPS; PRODUCTION AND DISTRIBUTION OF PRESCRIPTION DRUGS. 284. REPORTING. 285. PROPRIETARY INFORMATION. § 282. DEFINITIONS. AS USED IN THIS TITLE, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS: 1. "GENERIC DRUG" MEANS A DRUG THAT IS APPROVED PURSUANT TO SUBDIVI- SION (J) OF SECTION 355 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT (21 U.S.C. SEC. 301 ET SEQ.), OR A BIOSIMILAR, AS DEFINED UNDER THE FEDERAL PUBLIC HEALTH SERVICE ACT (42 U.S.C. SEC. 262). 2. "PARTNERSHIPS" SHALL INCLUDE, BUT ARE NOT LIMITED TO, AGREEMENTS FOR THE PROCUREMENT OF GENERIC PRESCRIPTION DRUGS BY WAY OF CONTRACTS OR PURCHASING BY A PAYER, STATE GOVERNMENTAL AGENCY, GROUP PURCHASING ORGANIZATION, NONPROFIT ORGANIZATION, OR OTHER ENTITY. § 283. PARTNERSHIPS; PRODUCTION AND DISTRIBUTION OF PRESCRIPTION DRUGS. 1. (A) THE COMMISSIONER SHALL ENTER INTO PARTNERSHIPS, CONSISTENT WITH PARAGRAPH (B) OF SUBDIVISION TWO OF THIS SECTION, IN CONSULTATION WITH ALL APPROPRIATE STATE AGENCIES AND THE DEPARTMENT OF HEALTH OR EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD08090-01-3
co-Sponsors
(D, WF) 56th Senate District
(D, WF) 48th Senate District
2023-S4786A (ACTIVE) - Details
2023-S4786A (ACTIVE) - Summary
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
2023-S4786A (ACTIVE) - Sponsor Memo
BILL NUMBER: S4786A SPONSOR: RIVERA TITLE OF BILL: An act to amend the public health law, in relation to enacting the "New York affordable drug manufacturing act" PURPOSE: Enacts the "New York Affordable Drug Manufacturing Act". SUMMARY OF SPECIFIC PROVISIONS: Section 1 provides a short title, the "New York Affordable Drug Manufac- turing Act." Section 2 amends article 2-A of the public health law by adding a new title IV, the New York Affordable Drug Manufacturing Act, which will help increase patient access to affordable drugs. This section provides definitions for the terms "generic prescription drug" and "partner- ships." This section provides language regarding criteria for the
2023-S4786A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 4786--A 2023-2024 Regular Sessions I N S E N A T E February 14, 2023 ___________ Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to enacting the "New York affordable drug manufacturing act" THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Short title. This act shall be known and may be cited as the "New York affordable drug manufacturing act". § 2. Article 2-A of the public health law is amended by adding a new title IV to read as follows: TITLE IV NEW YORK AFFORDABLE DRUG MANUFACTURING ACT SECTION 282. DEFINITIONS. 283. PARTNERSHIPS; PRODUCTION AND DISTRIBUTION OF GENERIC PRESCRIPTION DRUGS. 284. REPORTING. 285. PROPRIETARY INFORMATION. § 282. DEFINITIONS. AS USED IN THIS TITLE, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS: 1. "GENERIC PRESCRIPTION DRUG" MEANS A DRUG THAT IS APPROVED PURSUANT TO AN APPLICATION SUBMITTED UNDER SUBDIVISION (J) OF SECTION 355 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT (21 U.S.C. SEC. 301 ET SEQ.), OR A BIOSIMILAR, AS DEFINED UNDER THE FEDERAL PUBLIC HEALTH SERVICE ACT (42 U.S.C. SEC. 262) THAT IS NOT UNDER PATENT. 2. "PARTNERSHIPS" MEANS AGREEMENTS FOR THE PROCUREMENT OF GENERIC PRESCRIPTION DRUGS BY WAY OF CONTRACTS OR PURCHASING BY A PAYER, STATE GOVERNMENTAL AGENCY, GROUP PURCHASING ORGANIZATION, NONPROFIT ORGANIZA- TION, OR OTHER ENTITY. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD08090-02-3 S. 4786--A 2
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.